Neil W Gibson
CIK 1555918 · Chief Scientific Officer · last filed 2026-06-02
Neil W Gibson is a Chief Scientific Officer who has filed 36 SEC Form 4 insider transactions across 4 companies since 2012. The most recent filing, for STTK, was dated Jun 2, 2026. Across all open-market trades the lifetime net is −$2.4M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
36
-$2.42M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| STTK | Director | — | $4.94 | — | $0 | 7 | 2026-06-02 |
| TIL | Director | — | $7.92 | — | $0 | 5 | 2025-05-29 |
| TCR2 THERAPEUTICS INC. (TCRR) Delisted | Director | 493,791 | $1.48 | $730.8K | -$525.2K | 8 | 2023-06-01 |
| Regulus Therapeutics Inc. (RGLS) Delisted | Chief Scientific Officer | 8,655 | $8.16 | $70.6K | -$1.90M | 16 | 2015-01-30 |
Recent Filings
36 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-02 | STTK | Grant (A) | — | $0 | EDGAR |
| 2025-07-16 | STTK | Grant (A) | — | $0 | EDGAR |
| 2025-05-29 | TIL | Grant (A) | — | $0 | EDGAR |
| 2024-06-21 | STTK | Grant (A) | — | $0 | EDGAR |
| 2024-06-13 | TIL | Grant (A) | — | $0 | EDGAR |
| 2024-01-10 | TIL | Grant (A) | — | $0 | EDGAR |
| 2023-06-01 | TCR2 THERAPEUTICS INC. (TCRR) Delisted | Disp (D) | — | $0 | EDGAR |
| 2023-05-31 | STTK | Grant (A) | — | $0 | EDGAR |
| 2022-12-19 | TCR2 THERAPEUTICS INC. (TCRR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-10 | STTK | Grant (A) | — | $0 | EDGAR |